Larimar Therapeutics (LRMR) Shares Outstanding (Weighted Average): 2014-2024
Historic Shares Outstanding (Weighted Average) for Larimar Therapeutics (LRMR) over the last 11 years, with Dec 2024 value amounting to $63.8 million.
- Larimar Therapeutics' Shares Outstanding (Weighted Average) rose 393.05% to $15.4 million in Q4 2020 from the same period last year, while for Sep 2020 it was $15.4 million, marking a year-over-year increase of 393.10%. This contributed to the annual value of $63.8 million for FY2024, which is 45.33% up from last year.
- As of FY2024, Larimar Therapeutics' Shares Outstanding (Weighted Average) stood at $63.8 million, which was up 45.33% from $43.9 million recorded in FY2023.
- Larimar Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $63.8 million during FY2024, with a 5-year trough of $15.4 million in FY2020.
- For the 3-year period, Larimar Therapeutics' Shares Outstanding (Weighted Average) averaged around $50.3 million, with its median value being $43.9 million (2023).
- Data for Larimar Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY surged of 393.05% (in 2020) over the last 5 years.
- Larimar Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $15.4 million in 2020, then increased by 15.33% to $17.7 million in 2021, then soared by 144.31% to $43.3 million in 2022, then rose by 1.47% to $43.9 million in 2023, then spiked by 45.33% to $63.8 million in 2024.